Other

Pfizer buys biotech firm Seagen for $43 billion

US pharmaceutical giant Pfizer announced Monday that it had reached a deal to buy biotech firm Seagen, specializing in innovative cancer treatment, for $43 billion.

Health

How total abortion ban puts maternal health at risk

Pregnant patients in El Salvador, who, under the nation's abortion ban, had no choice but to carry fetuses with severe malformations to term, experienced high rates of maternal morbidity, according to new research by Harvard ...

Oncology & Cancer

New reports examine COVID's radiotherapy interruption implications

Two new reports from researchers at the University of Tennessee Health Science Center provide the first published description of unplanned interruptions in radiation cancer treatment across a major U.S. city in the COVID-19 ...

page 2 from 5